JNJ

187.01

-0.37%↓

ABT

124.76

+1.17%↑

TMO

565.5

+1.94%↑

ISRG

536.71

+0.94%↑

DHR

214.8

+0.69%↑

JNJ

187.01

-0.37%↓

ABT

124.76

+1.17%↑

TMO

565.5

+1.94%↑

ISRG

536.71

+0.94%↑

DHR

214.8

+0.69%↑

JNJ

187.01

-0.37%↓

ABT

124.76

+1.17%↑

TMO

565.5

+1.94%↑

ISRG

536.71

+0.94%↑

DHR

214.8

+0.69%↑

JNJ

187.01

-0.37%↓

ABT

124.76

+1.17%↑

TMO

565.5

+1.94%↑

ISRG

536.71

+0.94%↑

DHR

214.8

+0.69%↑

JNJ

187.01

-0.37%↓

ABT

124.76

+1.17%↑

TMO

565.5

+1.94%↑

ISRG

536.71

+0.94%↑

DHR

214.8

+0.69%↑

Home・Akciju saraksts・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Atvērts

6.52 2.84

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

6.32

Max

6.65

Galvenie mērījumi
By Trading Economics
Ienākumi	-1.5M -17M
Pārdošana	-5.2M 47M
Peļņas marža	-36.715
Darbinieki	477
EBITDA	-1.4M -14M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+31.77% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2025. g. 6. nov.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	80M 433M
Iepriekšējā atvēršanas cena	3.68
Iepriekšējā slēgšanas cena	6.52

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

7.16 / 7.65 Atbalsts un pretestība

Treace Medical Concepts Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 3. nov. 21:44 UTC

Peļņas

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

2025. g. 3. nov. 23:44 UTC

Tirgus saruna

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

2025. g. 3. nov. 23:34 UTC

Tirgus saruna

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

2025. g. 3. nov. 23:28 UTC

Peļņas

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

2025. g. 3. nov. 23:24 UTC

Peļņas

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

2025. g. 3. nov. 23:14 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Global Equities Roundup: Market Talk

2025. g. 3. nov. 23:14 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

2025. g. 3. nov. 23:12 UTC

Peļņas

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

2025. g. 3. nov. 23:09 UTC

Peļņas

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

2025. g. 3. nov. 23:09 UTC

Peļņas

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

2025. g. 3. nov. 23:09 UTC

Peļņas

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

2025. g. 3. nov. 23:06 UTC

Tirgus saruna

Peļņas

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

2025. g. 3. nov. 22:36 UTC

Tirgus saruna

Peļņas

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

2025. g. 3. nov. 22:31 UTC

Peļņas

Franco-Nevada 3Q EPS $1.49 >FNV

2025. g. 3. nov. 22:31 UTC

Peļņas

Franco-Nevada 3Q Rev $487.7M >FNV

2025. g. 3. nov. 22:24 UTC

Tirgus saruna

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

2025. g. 3. nov. 22:19 UTC

Iegādes, apvienošanās, pārņemšana

Starbucks Agrees to Sell Stake in China Business -- WSJ

2025. g. 3. nov. 21:59 UTC

Tirgus saruna

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

2025. g. 3. nov. 21:54 UTC

Tirgus saruna

Peļņas

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

2025. g. 3. nov. 21:54 UTC

Tirgus saruna

Peļņas

Global Equities Roundup: Market Talk

2025. g. 3. nov. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 3. nov. 21:49 UTC

Peļņas

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

2025. g. 3. nov. 21:40 UTC

Peļņas

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

2025. g. 3. nov. 21:31 UTC

Tirgus saruna

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

2025. g. 3. nov. 21:19 UTC

Peļņas

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

2025. g. 3. nov. 21:11 UTC

Iegādes, apvienošanās, pārņemšana

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

2025. g. 3. nov. 21:11 UTC

Peļņas

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

2025. g. 3. nov. 21:07 UTC

Peļņas

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

2025. g. 3. nov. 21:05 UTC

Peļņas

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

2025. g. 3. nov. 21:05 UTC

Peļņas

Palantir Technologies 3Q Net $475.6M >PLTR

Salīdzinājums

Cenas izmaiņa

Treace Medical Concepts Inc Prognoze

Cenas mērķis

By TipRanks

31.77% augšup

Prognoze 12 mēnešiem

Vidējais 8.42 USD 31.77%

Augstākais 12 USD

Zemākais 6 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Treace Medical Concepts Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

6 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 6 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Treace Medical Concepts Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

7.16 / 7.65Atbalsts un pretestība

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.